Oncotarget

Research Papers:

FEN1 gene variants confer reduced risk of breast cancer in chinese women: A case-control study

Shuai Lin, Meng Wang, Xinghan Liu, Ye Lu, Zhuoqing Gong, Yan Guo, Pengtao Yang, Tian Tian, Cong Dai, Yi Zheng, Peng Xu, Shanli Li, Yuyao Zhu and Zhijun Dai _

PDF  |  HTML  |  How to cite

Oncotarget. 2016; 7:78110-78118. https://doi.org/10.18632/oncotarget.12948

Metrics: PDF 1198 views  |   HTML 1824 views  |   ?  


Abstract

Shuai Lin1,*, Meng Wang1,*, Xinghan Liu1,*, Ye Lu2, Zhuoqing Gong3, Yan Guo4, Pengtao Yang1, Tian Tian1, Cong Dai1, Yi Zheng1, Peng Xu1, Shanli Li1, Yuyao Zhu1, Zhijun Dai1

1Department of Oncology, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China

2Department of Student Affairs, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China

3Department of Health Science Center, Xi’an Jiaotong University, Xi’an 710061, China

4Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an 710049, China

*These authors have contributed equally to this work

Correspondence to:

Zhijun Dai, email: [email protected]

Keywords: flap endonuclease 1, breast cancer, risk, case-control study

Received: July 28, 2016    Accepted: October 14, 2016    Published: October 27, 2016

ABSTRACT

This study aimed to assess the associations of two common Flap endonuclease 1 (FEN1) polymorphisms (rs4246215 and rs174538) with breast cancer risk in northwest Chinese women. We conducted a case-control study with 560 breast cancer patients and 583 age-matched healthy controls from Northwest China. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were used to estimate the associations. We found a significantly reduced risk of breast cancer associated with T allele of rs4246215 (allele model: OR 0.81, 95% CI 0.68–0.96; homozygote model: OR = 0.59, 95% CI = 0.40–0.87; recessive model: OR = 0.61, 95% CI = 0.42–0.89), especially in postmenopausal women (OR = 0.58, 95% CI = 0.35–0.97). Furthermore, the polymorphism showed a decreased association with larger tumor size (heterozygote model: OR = 0.63, 95% CI = 0.44–0.92; dominant model: OR = 0.63, 95% CI = 0.44–0.90). For rs174538, we did not find any difference in all genetic models. However, rs174538 was associated with lymph node metastasis (heterozygote model: OR = 0.57, 95% CI = 0.39–0.81; dominant model: OR = 0.61, 95% CI = 0.43–0.86) and estrogen receptor status (heterozygote model: OR = 1.50, 95% CI = 1.05–2.15; dominant model: OR = 1.42, 95% CI = 1.01–1.98). Haplotype analysis showed that Trs4246215Grs174538 haplotype was a protective factor of breast cancer (OR = 0.34, 95% CI = 0.14–0.81). Our results suggest that FEN1 polymorphisms may reduce the risk of breast cancer in Chinese women.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 12948